Rutgers logo
School of Environmental and Biological Sciences
Rutgers logo
School of Environmental and Biological Sciences
  • Events
  • Doctoral Dissertation Defense - Meifan Zhang

Doctoral Dissertation Defense - Meifan Zhang

Date & Time

Wednesday, August 05, 2026, 12:00 p.m.-1:00 p.m.

Category

Location

Online and Center for Advanced Biotechnology and Medicine (CABM) Room 010

679 Hoes Lane West Piscataway, NJ, 08854

Contact

Lindsay Vasy

Microbial Biology Graduate Program

Meifan Zhang MB Defense

Doctoral Dissertation Defense

Meifan Zhang

"Systemic Effects of Early-Life, Low-Dose Penicillin on Metabolic Organs to Promote Adiposity in a Mouse Model"

Committee Members: Dr Martin Blaser (Advisor), Dr. Judith Storch, Dr. Christoph Buettner, Dr. Xiaoyang Su

Zoom Details for Dissertation Defense

Please email Lindsay Vasy for information (lindsay.vasy@rutgers.edu).

Dissertation Summary

Although obesity is a global epidemic, its pathogenesis remains largely obscure. Previous experimental models using low-dose antibiotics, a historical agricultural growth-promotion strategy, have linked early-life exposure to later-life obesity. Grounded in the Developmental Origins of Health and Disease (DOHaD) framework, this dissertation investigates how antibiotic-induced microbiome disruptions during critical developmental windows alter metabolism, predisposing young mice to adult obesity.

Focusing on adipose tissue and the liver, we exposed murine pups to low-dose penicillin (LDP) from birth for 1, 2, or 4 weeks, followed by dietary or environmental stressors. LDP exposure accelerated early gains in body weight and fat mass, effects synergistically exacerbated by a high-fat diet. Remarkably, by postnatal day 7, LDP-treated mice had increased hepatic and adipose mass that persisted through weaning, accompanied by disturbances in the growth hormone (GH) and insulin-like growth factor 1 (IGF-1) somatotrophic axis. Ligilactobacillus was identified as a key protective bacterial taxon. Ultimately, these data demonstrate that microbiome perturbations during a critical early-life window alter metabolic organs and endocrine regulatory systems, driving accelerated growth and the pathogenesis of obesity.